Five Prime Therapeutics, Inc. Proceeds from Common Stock Issued
Five Prime Therapeutics, Inc. reported Proceeds from Common Stock Issued of $163.21 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2021-03-22
- Five Prime Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2020-12-31 was $163.18M.
- Five Prime Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2018-12-31 was -$1.00K.
- Five Prime Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2018-09-30 was $0.00.
- Five Prime Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2018-06-30 was $0.00.
- Five Prime Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2020 was $163.21M.
- Five Prime Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2018 was $107.61M.
- Five Prime Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2015 was $78.69M, a 34.00% increase from fiscal 2014.
- Five Prime Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2014 was $58.73M, a 8.02% decline from fiscal 2013.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 1 month as first filed | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | $163.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $163.21M 10-K · filed 2021-03-22 | |||||
| 2020-11-30 | $163.20K 10-K · filed 2021-03-22 | ||||||
| 2020-09-30 | $32.00K 10-Q · filed 2020-11-03 | ||||||
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$1.00K derived: sum of 2 quarters · filed 2021-03-22 | -$1.00K derived: sum of 3 quarters · filed 2021-03-22 | $107.61M 10-K · filed 2021-03-22 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $107.61M 10-Q · filed 2019-11-06 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $107.61M 10-Q · filed 2019-08-08 | |||||
| 2018-03-31 | $107.61M 10-Q · filed 2019-05-09 | ||||||
| 2018-01-31 | $107.60K 10-K · filed 2021-03-22 | $107.60M 10-K · filed 2019-02-26 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $78.69M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $78.69M 10-Q · filed 2016-11-04 | $97.32M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $78.69M 10-Q · filed 2016-08-05 | $97.32M derived: sum of 3 quarters · filed 2017-02-24 | $118.79M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-03-31 | $78.69M 10-Q · filed 2016-05-06 | $97.32M derived: sum of 2 quarters · filed 2017-02-24 | $118.79M derived: sum of 3 quarters · filed 2017-02-24 | $118.78M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-01-31 | $78.70M 10-Q · filed 2015-11-05 | ||||||
| 2014-12-31 | $18.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $40.10M derived: sum of 2 quarters · filed 2017-02-24 | $40.09M derived: sum of 3 quarters · filed 2017-02-24 | $58.73M 10-K · filed 2017-02-24 | |||
| 2014-09-30 | $21.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $21.46M derived: sum of 2 quarters · filed 2015-11-05 | $40.10M 10-Q · filed 2015-11-05 | $18.63M 10-Q · filed 2014-11-12 | $39.06M derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $18.63M 10-Q · filed 2015-08-07 | $17.59M derived: sum of 3 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $18.64M 10-Q · filed 2015-05-14 | $17.60M derived: sum of 2 quarters · filed 2016-03-11 | |||||
| 2013-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $63.85M 10-K · filed 2016-03-11 | |||||
| 2013-09-30 | $63.80M 10-K · filed 2014-03-26 | $64.89M 10-Q · filed 2013-11-13 |